About BioCentriq
BioCentriq is a full service CDMO. We offer product development and clinical production for cell and gene therapies. BioCentriq was founded in 2019 and launched our pilot development plant at the same time. In October of 2020 we completed the validation of our GMP center and opened the doors for clinical manufacturing.
Our mission is to accelerate the advancement of cell and gene therapies by improving the efficiency and effectiveness of manufacturing processes and technologies. To support that mission, we also offer custom and standard workforce development programs to help close the skills gap that exists in the industry today.
Learn More

ISO-7
Certified Clinical Production

BSL-2
Certified Process Development

3
Facilities in New Jersey

2019
Year Founded
Recent Updates
Cutting-Edge Cell & Gene Therapy Manufacturing Center, BioCentriq™ Opens in Newark, New Jersey
October 29, 2020Choosing a CDMO: Top 10 Intangibles Biotech Firms Should Consider
October 22, 2020Virtual Ribbon Cutting of BioCentriq™ Scheduled for October 29th at 2:30pm
October 21, 2020Viral Vector Market Projected to Grow Exponentially, Increasing Demand for Skilled Workforce
October 14, 2020Get In Touch
Please use the form below to get in touch with a member of our team.